Related Experiment Videos
Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover
Ding Xie1, Hua Cheng, Mark Hamrick
1Institute of Molecular Medicine and Genetics, Medical College of Georgia, Department of Medicine, CB-2803, 1120 15th Street, Augusta, GA 30912, USA.
Bone
|October 13, 2005
Summary
Glucose-dependent insulinotropic polypeptide (GIP) promotes bone formation and quality. GIP receptor knockout mice show reduced bone mass and earlier age-related changes, highlighting GIP's anabolic role in bone metabolism.
Area of Science:
- Endocrinology
- Bone Biology
- Metabolic Research
Background:
- Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone secreted post-meal.
- In vitro studies suggest GIP influences osteoblastic function.
- In vivo effects of GIP on bone remodeling are not well understood.
Purpose of the Study:
- Investigate the in vivo role of GIP in bone turnover.
- Evaluate GIP receptor knockout (GIPR-/-) mice for bone density, morphology, and strength.
- Determine GIP's impact on bone formation and age-related changes.
Main Methods:
- Utilized GIP receptor knockout (GIPR-/-) mice and wild-type controls.
- Assessed serum bone turnover markers over five months.
- Analyzed bone density, microarchitecture, biomechanical properties, and body composition.
Main Results:
- GIPR-/- mice exhibited decreased bone size, mass, and altered microarchitecture.
- Bone turnover parameters, particularly bone formation, were significantly affected.
- Site-specific effects and compensatory mechanisms influenced bone mass over time.
- GIPR-/- mice showed earlier age-related changes in body composition.
Conclusions:
- GIP demonstrates an anabolic effect on bone mass and quality.
- GIP signaling is crucial for maintaining bone health and preventing premature aging.
- GIP may serve as a hormonal link between nutrient intake and bone metabolism.